Can Denmark's world-beating drugs maker Novo Nordisk stay ahead after Wegovy propelled them into the big league? business Article 1027 words 8 votes
Something is golden in the state of Denmark – can Novo Nordisk's success really be a problem for the Danish economy? economics business Article 1102 words, published Oct 16 2023 8 votes
Novo Nordisk, the maker of weight-loss drug Wegovy has become Europe's most valuable firm, dethroning the French luxury conglomerate LVMH business Article 20 votes
Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country's economic growth business economics Article 1361 words 6 votes
America's obsession with weight-loss drugs is affecting the economy of Denmark – Novo Nordisk's market capitalization has matched the GDP of its home country economics business Article 17 votes